Tissue Citations
OriGene产品已被全世界的科学家广泛使用,以提高他们的研究效率。 为了供您参考,我们收集了一些使用OriGene产品发表过的代表性的引用文献,将其发布在此页面上。
使用基因名称或靶标名称搜索文献
这是研究人员使用OriGene产品后最新发表的一些论文。
靶点 | 研究论文 | 杂志 | 产品类型 | 货号 |
---|---|---|---|---|
cfDNA methylome profiling for detection and subtyping of small cell lung cancers | Nature Cancer | Tissue | CD563113 | |
Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin | Cancer discovery | Tissue | CD564011 | |
Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin | Cancer discovery | Tissue | CD564404 | |
Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules | Science Advances | Tissue | CS804207 | |
Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin’s glucose-lowering effects | Science translational medicine | Tissue | CS617749 | |
α-Actinin-4 promotes metastasis in gastric cancer. | Laboratory investigation; a journal of technical methods and pathology | Tissue | CR561840 | |
The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer | Int J Mol Sci | Tissue | CT565858 | |
BASIC AND TRANSLATIONAL—BILIARY | Gastroenterology | Tissue | CS601377 | |
Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation | Tumour Biol. | Tissue | CP565603 | |
Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation | Tumour Biol. | Tissue | CP565410 | |
The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-ß1 signaling: implications in hepatocellular carcinogenesis | Am J Cancer Res | Tissue | CP565754 | |
The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-ß1 signaling: implications in hepatocellular carcinogenesis | Am J Cancer Res | Tissue | CP641361 | |
The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-ß1 signaling: implications in hepatocellular carcinogenesis | Am J Cancer Res | Tissue | CP19427 | |
The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-ß1 signaling: implications in hepatocellular carcinogenesis | Am J Cancer Res | Tissue | CP607175 | |
The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-ß1 signaling: implications in hepatocellular carcinogenesis | Am J Cancer Res | Tissue | CP532216 | |
The prognostic significance of specific HOX gene expression patterns in ovarian cancer | Int. J. Cancer | Tissue | CR562470 | |
The prognostic significance of specific HOX gene expression patterns in ovarian cancer | Int. J. Cancer | Tissue | CR561036 | |
Peroxisome Proliferator-Activated Receptor ? Level Contributes to Structural Integrity and Component Production of Elastic Fibers in the Aorta | Hypertension | Tissue | CS808048 | |
Uptake of ascorbic acid by pancreatic acinar cells is negatively impacted by chronic alcohol exposure | Am. J. Physiol., Cell Physiol. | Tissue | CR560122 | |
Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment | Sci Rep | Tissue | CS510525 | |
Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain | Drug Metab. Dispos. | Tissue | CR559097 | |
Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain | Drug Metab. Dispos. | Tissue | CR559974 | |
Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain | Drug Metab. Dispos. | Tissue | CR562323 | |
Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain | Drug Metab. Dispos. | Tissue | CR563018 | |
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer | Human Gene Therapy | Tissue | CR560122 | |
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer | Human Gene Therapy | Tissue | CR560156 | |
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer | Human Gene Therapy | Tissue | CR560781 | |
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer | Human Gene Therapy | Tissue | CR560929 | |
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer | Human Gene Therapy | Tissue | CR561392 | |
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer | Human Gene Therapy | Tissue | CR561533 | |
Interleukin-17 Cytokines Are Critical in Development of Fatal Lupus Glomerulonephritis | Immunity | Tissue | CR560624 | |
Interleukin-17 Cytokines Are Critical in Development of Fatal Lupus Glomerulonephritis | Immunity | Tissue | CR560857 | |
QKI-Mediated Alternative Splicing of the Histone Variant MacroH2A1 Regulates Cancer Cell Proliferation | Molecular and Cellular Biology | Tissue | CR559970 | |
Adecarcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget | tissue | CP565398 |
Adecarcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget | tissue | CP565411 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR550145 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR559187 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR559317 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR560116 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR560023 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR560217 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR560317 |
Adenocarcinoma | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR559424 |
Adenocarcinoma of Breast | Predicting cell lineages using autoencoders and optimal transport | PLoS Comput. Biol. | Tissue | CS548359 |
Adenocarcinoma of breast | Autoencoder and Optimal Transport to Infer Single-Cell Trajectories of Biological Processes | bioRxiv | Tissue | CS548359 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR560973 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR559251 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR560080 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR560367 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR560476 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR560603 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR560671 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep | Tissue | CR561163 |
Adenocarcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565638 |
Adenocarcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565414 |
Adenocarcinoma of ovary | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep. | Tissue | CP565528 |
Adenocarcinoma of ovary | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep. | Tissue | CP565532 |
Adenocarcinoma of pancreas | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer | Mol. Cancer | Tissue | CD564012 |
Adenocarcinoma of pancreas | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer | Mol. Cancer | Tissue | CD563941 |
adenocarcinoma tissue sections | Proteomic Analysis of Temporally Stimulated Ovarian Cancer Cells for Biomarker Discovery | Mol. Cell. Proteomics, Feb 2013; 12: 356 - 368. | Tissue | CS600781 |
Aneurysm | A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms | Atherosclerosis | Tissue | CS801609 |
Aorta | A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms | Atherosclerosis | Tissue | CS808048 |
Atherosclerosis | Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction | J Smooth Muscle Res | Tissue | CS808380 |
Brain Protein Lysate | Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway | FEBS Lett. 2013 Oct 11. pii: S0014-5793(13)00724-2 | Tissue | CP565621 |
Brain Protein Lysate | Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway | FEBS Lett. 2013 Oct 11. pii: S0014-5793(13)00724-2 | Tissue | CP565723 |
Brain Protein Lysate | Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway | FEBS Lett. 2013 Oct 11. pii: S0014-5793(13)00724-2 | Tissue | CP565732 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv | Tissue | CR560317 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv | Tissue | CR560615 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv | Tissue | CR560023 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv | Tissue | CR560116 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS520016 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS537806 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS521057 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS505265 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS555577 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS532986 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS523709 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS607643 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS527811 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis | Tissue | CS527834 |
Breast Cancer Protein Lysate | IB Kinase Phosphorylates TRAF2 To Promote Mammary Epithelial Cell Transformation | Mol. Cell. Biol., Dec 2012; 32: 4756 - 4768. | Tissue | CP624650 |
Breast Cancer Tissues | MicroRNA-542-3p Inhibits Tumor Angiogenesis by Targeting Angiopoietin2 | J. Pathol., Jan 2014. | Tissue | |
Breast Tissue Lysates | Using a cell line breast cancer progression system to identify biomarker candidates | J Proteomics | Tissue | |
Breast Tissue Sections | STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors | Nature Medicine 16, 1421-1428 (21 November 2010) doi:10.1038/nm.2250 Article | Tissue | |
Breast Tumor Tissue | Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression | Nat. Med. | Tissue | |
Breast Tumor Tissue FFPE | Broad Cross-Presentation of the Hematopoietically Derived PR1 Antigen on Solid Tumors Leads to Susceptibility to PR1-Targeted Immunotherapy | J. Immunol., Dec 2012; 189: 5476 - 5484. | Tissue | CS811219 |
Cancer Survey | The antiangiogenic role of the pro-inflammatory cytokine interleukin-31 | Oncotarget | Tissue | CT565858 |
Cancer tissue microarrays | Casein Kinase 1{varepsilon} Promotes Cell Proliferation by Regulating mRNA Translation | Cancer Res. Dec 2013. | Tissue | CT565858 |
Carcinoma of liver | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep. | Tissue | CP565477 |
Carcinoma of liver | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep. | Tissue | CP520741 |
Carcinoma of lung | Dodging COVID-19 Infection: Low Expression and Localization of ACE2 and TMPRSS2 in Human Umbilical Cord-Derived Mesenchymal Stem Cells | Research Square | Tissue | CP565586 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565643 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565586 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565564 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565534 |
Carcinoma of lung, large cell | Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells | Journal of translational medicine | Tissue | CP565586 |
Cardiomyopathy | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR561340 |
Cardiomyopathy | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR562037 |
CD563113 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563113 |
CD563113 | MIRA-seq for DNA methylation analysis of CpG islands | Epigenomics | Tissue | CD563113 |
CD563185 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563185 |
CD563248 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563248 |
CD563253 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563253 |
CD563356 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563356 |
CD563440 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563440 |
CD563566 | Comparison of custom capture for targeted next-generation DNA sequencing | J Mol Diagn | Tissue | CD563566 |
CD563715 | Comparison of custom capture for targeted next-generation DNA sequencing | J Mol Diagn | Tissue | CD563715 |
CD563740 | Comparison of custom capture for targeted next-generation DNA sequencing | J Mol Diagn | Tissue | CD563740 |
CD563753 | Comparison of custom capture for targeted next-generation DNA sequencing | J Mol Diagn | Tissue | CD563753 |
CD563851 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563851 |
CD563929 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563929 |
CD563933 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563933 |
CD563968 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD563968 |
CD564039 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564039 |
CD564276 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564276 |
CD564276 | Comparison of custom capture for targeted next-generation DNA sequencing | J Mol Diagn | Tissue | CD564276 |
CD564391 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564391 |
CD564492 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564492 |
CD564677 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564677 |
CD564695 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564695 |
CD564795 | Comparison of custom capture for targeted next-generation DNA sequencing | J Mol Diagn | Tissue | CD564795 |
CD564857 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564857 |
CD564860 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564860 |
CD564879 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564879 |
CD564881 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564881 |
CD564893 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564893 |
CD564893 | Comparison of custom capture for targeted next-generation DNA sequencing | J Mol Diagn | Tissue | CD564893 |
CD564907 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564907 |
CD564918 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564918 |
CD564940 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD564940 |
CD565292 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD565292 |
CD565298 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD565298 |
CD565340 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CD565340 |
Cervical Adenocarcinoma | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR561176 |
Cervical Adenocarcinoma | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR561219 |
Cervical Adenocarcinoma | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR559855 |
Colitis, ulcerative, chronic active | Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy | Scientific reports | Tissue | CR562039 |
Colitis, ulcerative, chronic active | Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy | Scientific reports | Tissue | CR561525 |
Colitis, ulcerative, chronic active | Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy | Scientific reports | Tissue | CR560265 |
Colon Cancer | Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients | PLoS ONE | Tissue | CT565864 |
Colon RNA | Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants | Int J Cancer. 2013 Oct 23 | Tissue | CR560347 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR559521 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560523 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560590 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR561060 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560603 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR559251 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560527 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560026 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560080 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560671 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560126 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560367 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560476 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560973 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR560403 |
Colorectal cancer | A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes | bioRxiv | Tissue | CR561163 |
CP565666 | Metabolic Imaging of Pancreatic Ductal Adenocarcinoma Detects Altered Choline Metabolism | Clin. Cancer Res. | Tissue | CP565666 |
CP565751 | PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation | Nat Commun | Tissue | CP565751 |
CP607175 | PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation | Nat Commun | Tissue | CP607175 |
CR559081 | Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system | Pflügers Archiv - European Journal of Physiology | Tissue | CR559081 |
CR559104 | Hierarchical clustering of breast cancer methylomes revealed differentially methylated and expressed breast cancer genes | PLoS ONE | Tissue | CR559104 |
CR559502 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR559502 |
CR559685 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR559685 |
CR560027 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR560027 |
CR560067 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR560067 |
CR560288 | A resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues | Sci Data | Tissue | CR560288 |
CR560393 | A resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues | Sci Data | Tissue | CR560393 |
CR560480 | Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-a on osteoblast marker expression induced by bone morphogenetic protein-2 | Peptides | Tissue | CR560480 |
CR560566 | A small subunit processome protein promotes cancer by altering translation | Oncogene | Tissue | CR560566 |
CR560635 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR560635 |
CR560748 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR560748 |
CR561074 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR561074 |
CR561143 | Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type | J. Pathol. | Tissue | CR561143 |
CR561262 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR561262 |
CR561840 | A resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues | Sci Data | Tissue | CR561840 |
CR561898 | Hierarchical clustering of breast cancer methylomes revealed differentially methylated and expressed breast cancer genes | PLoS ONE | Tissue | CR561898 |
CR561982 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR561982 |
CR562102 | Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type | J. Pathol. | Tissue | CR562102 |
CR562152 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562152 |
CR562237 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562237 |
CR562252 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562252 |
CR562370 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562370 |
CR562502 | Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-a on osteoblast marker expression induced by bone morphogenetic protein-2 | Peptides | Tissue | CR562502 |
CR562657 | Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis | Nature Communications Dec2015 | Tissue | CR562657 |
CR562696 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562696 |
CR562868 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562868 |
CR562901 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562901 |
CR562983 | The DNA methylation landscape of human melanoma | Genomics | Tissue | CR562983 |
CS500965 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS500965 |
CS501784 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS501784 |
CS502022 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS502022 |
CS504597 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS504597 |
CS507565 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS507565 |
CS509788 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS509788 |
CS512724 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS512724 |
CS516287 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS516287 |
CS517945 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS517945 |
CS519051 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS519051 |
CS520158 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS520158 |
CS520230 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS520230 |
CS521575 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS521575 |
CS525565 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS525565 |
CS536817 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS536817 |
CS601514 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS601514 |
CS604708 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS604708 |
CS610749 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS610749 |
CS611379 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS611379 |
CS618295 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS618295 |
CS618945 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS618945 |
CS701517 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS701517 |
CS701518 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS701518 |
CS706542 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS706542 |
CS802272 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS802272 |
CS802273 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS802273 |
CS804360 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS804360 |
CS804516 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS804516 |
CS807956 | Toll-Like Receptor 4 Is Essential in the Development of Abdominal Aortic Aneurysm | PLoS ONE | Tissue | CS807956 |
CS808048 | Toll-Like Receptor 4 Is Essential in the Development of Abdominal Aortic Aneurysm | PLoS ONE | Tissue | CS808048 |
CS811958 | DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression | Cancer Res. | Tissue | CS811958 |
CS814500 | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma | Cancer Sci. | Tissue | CS814500 |
CT565907 | CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma | BMC Cancer | Tissue | CT565907 |
Fallopian tubes | Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma | Oncotarget | Tissue | CR559726 |
FFPE Sections | Merkel cell polyomavirus small T antigen drives cell motility via Rho-GTPase-induced filopodia formation | J. Virol.2017 | Tissue | CS815038 |
four normal thyroid tissue specimens | Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies | J. Clin. Endocrinol. Metab., Dec 2011; 96: E2023 - E2028. | Tissue | |
Frozen Tumor Samples | Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response | Cancer Res., Jul 2012; 72: 3153 - 3162. | Tissue | |
Gastric RNA | Gastrin Induces Parathyroid Hormone-Like Hormone Expression in Gastric Parietal Cells | Am. J. Physiol. Gastrointest. Liver Physiol. | Tissue | CR561571 |
HB2010 | The Novel Tail-anchored Membrane Protein Mff Controls Mitochondrial and Peroxisomal Fission in Mammalian Cells | Mol. Biol. Cell. 2008; 19(6): p. 2402-2412 | Tissue | |
HB2010 | Synergistic upregulation of erythropoietin receptor (EPO-R) expression by sense and antisense EPO-R transcripts in the canine lung | PNAS. 2008; 105(21): p. 7612-7617 | Tissue | |
HCC Tissues | Involvement of androgen receptor and glucose-regulated protein 78kDa in human hepatocarcinogenesis | Exp. Cell Res. | Tissue | |
Heart valve disorder | Collagen Networks within 3D PEG Hydrogels Support Valvular Interstitial Cell Matrix Mineralization | SSRN Journal | Tissue | CS508070 |
human breast cancer tissue protein lysates | Phosphatidylinositol 4-phosphate in the Golgi apparatus regulates cell-cell adhesion and invasive cell migration in human breast cancer | Cancer Res. April 2014 | Tissue | |
Human Lung total rna | Role of Sonic Hedgehog in idiopathic pulmonary fibrosis | Am J Physiol Lung Cell Mol Physiol, Dec 2012; 303: L978 - L990. | Tissue | HT1009 |
Human ovarian cancer samples RNAs | Akt2 Regulates All Akt Isoforms and Promotes Resistance to Hypoxia through Induction of miR-21 upon Oxygen Deprivation | Cancer Res., Jul 2011; 71: 4720 - 4731. | Tissue | |
Human Ovary | Structure and expression of the long noncoding RNA gene MIR503 in humans and non-human primates | Mol. Cell. Endocrinol. | Tissue | CR561036 |
Human Sarcoma Samples | The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity | British Journal of Cancer doi:10.1038/bjc.2013.421 | Tissue | |
Human Testis | Structure and expression of the long noncoding RNA gene MIR503 in humans and non-human primates | Mol. Cell. Endocrinol. | Tissue | CR562848 |
Human Testis Total RNA | Intronic Promoter Drives the BORIS-regulated Expression of FerT in Colon Carcinoma Cells | J. Biol. Chem., Feb 2012; 287: 6100 - 6112. | Tissue | |
Human Tissue cDNAs | SHON Is a Novel Estrogen-Regulated Oncogene in Mammary Carcinoma That Predicts Patient Response to Endocrine Therapy | Cancer Res. Dec 2013. | Tissue | |
Intratubular germ cell neoplasia of testis | A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells | Int J Mol Sci | Tissue | CR561785 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR563036 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR561473 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR560088 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR561100 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR560907 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR559302 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR561841 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR559768 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR562065 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR562155 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR562805 |
Kidney Cancer | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR562761 |
Kidney Cancer Tissue Microarray | HIF2α targeted RNAi therapeutic inhibits clear cell renal cell carcinoma | Mol. Cancer Ther.2017 | Tissue | CT565907 |
Large cell carcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget | tissue | CP565586 |
Large cell carcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget | tissue | CP565534 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS809425 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS705545 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS709226 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS711415 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS711728 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS712499 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS804723 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS805117 |
Leiomyosarcoma | The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing | Am. J. Obstet. Gynecol. | Tissue | CS807036 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR559232 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR559715 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR561521 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR562036 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR562331 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR560083 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR560771 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR560135 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR562426 |
Lung Cancer | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR561778 |
Lung Cancer | Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization | Nat Commun | Tissue | CT565899 |
Lung Cancer | N-glycan structures of human alveoli provide insight into influenza A virus infection and pathogenesis | FEBS J. | Tissue | CB610551 |
Lung Cancer | Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p | Mol. Carcinog. | Tissue | CP565586 |
Lung Cancer | Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p | Mol. Carcinog. | Tissue | CP565534 |
Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square | Tissue | CP565585 |
Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square | Tissue | CP565542 |
Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square | Tissue | CP565443 |
Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square | Tissue | CR559346 |
Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square | Tissue | CR560789 |
Lung Normal | Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs). | Research Square | Tissue | CR562469 |
LYPD6B | Doublecotin-like kinase 1 increases chemoresistance of colorectal cancer cells through the anti-apoptosis pathway | bioRxiv | Tissue | CT116 |
Muscle RNA | Myocilin Stimulates Osteogenic Differentiation of Mesenchymal Stem Cells through Mitogen-activated Protein Kinase Signaling | J. Biol. Chem., Jun 2013; 288: 16882 - 16894. | Tissue | |
Nephritis, tubulointerstitial, chronic | Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions | EBioMedicine | Tissue | CS700464 |
Nephritis, tubulointerstitial, chronic | Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions | EBioMedicine | Tissue | CS705284 |
Normal | Identification and quantification of DNA repair protein poly(ADP ribose) polymerase 1 (PARP1) in human tissues and cultured cells by liquid chromatography/isotope-dilution tandem mass spectrometry | DNA Repair (Amst.) 2019 | Tissue | CP565394 |
Normal | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv | Tissue | CR559173 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR562944 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR561460 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR560086 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR559748 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR560906 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR560658 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR559696 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR561775 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR559241 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR559708 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR562804 |
Normal | Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma | Oncotarget | Tissue | CR562762 |
Normal | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR516938 |
Normal | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR518992 |
Normal | RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells | Int. J. Biochem. Cell Biol. | Tissue | CR559063 |
Normal | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget | tissue | CP565391 |
Normal | Resolvin D1 binds human phagocytes with evidence for proresolving receptors | PNAS, Jan 2010; 107: 1660 - 1665 | Tissue | |
Normal and Carcinoma | Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution | Nature Methods 7, 133-136 (10 January 2010) doi:10.1038/nmeth.1414 Brief Communication | Tissue | |
Normal Breast | Autoencoder and Optimal Transport to Infer Single-Cell Trajectories of Biological Processes | bioRxiv | Tissue | CS708873 |
Normal Breast | Next-Generation Whole Transcriptome Sequencing of Triple-Negative Breast Tumors and Normal Tissues | Cancer Res., Dec 2009; 69: 6134 | Tissue | |
Normal Cervix | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR559475 |
Normal Cervix | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR561069 |
Normal Cervix | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep. | Tissue | CR563004 |
normal human liver | Genome-Wide Methylation Mapping Using Nanopore Sequencing Technology Identifies Novel Tumor Suppressor Genes in Hepatocellular Carcinoma | International Journal of Molecular Sciences | Tissue | CR562274 |
Normal Human Pancreas Tissue | GSK-3β Phosphorylates and Stabilizes HLXB9 in Insulinoma Cells to Form a Targetable Mechanism of Controlling Insulinoma Cell Proliferation | J. Biol. Chem., Jan 2014. | Tissue | |
Normal Limits | Predicting cell lineages using autoencoders and optimal transport | PLoS Comput. Biol. | Tissue | CS708873 |
Normal limits | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep. | Tissue | CP520759 |
Normal limits | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep. | Tissue | CP565745 |
Normal limits | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep. | Tissue | CP565549 |
Normal Limits | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565585 |
Normal Limits | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res. | Tissue | CP565577 |
Normal Limits | A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells | Int J Mol Sci | Tissue | CR562185 |
Normal Limits | A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells | Int J Mol Sci | Tissue | CR562933 |
Normal Limits | A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells | Int J Mol Sci | Tissue | CR561981 |
Normal Limits | The Landscape of Circular RNA in Cancer | Cell | Tissue | CR559716 |
Normal Limits | The Landscape of Circular RNA in Cancer | Cell | Tissue | CR559724 |
Normal Limits | The Landscape of Circular RNA in Cancer | Cell | Tissue | CR561975 |
Normal Limits | The Landscape of Circular RNA in Cancer | Cell | Tissue | CR560592 |
Normal Limits | The Landscape of Circular RNA in Cancer | Cell | Tissue | CR560901 |
Normal Limits | The Landscape of Circular RNA in Cancer | Cell | Tissue | CR560916 |
Normal Lung | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR560789 |
Normal Lung | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR562469 |
Normal Lung | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR559346 |
Normal Lung | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR562690 |
Normal Lung | Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis | EBioMedicine | Tissue | CR561266 |
Normal Ovary | Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer | BMC Cancer | Tissue | CR560115 |
Normal Skin | Mogamulizumab treatment elicits autoantibodies attacking the skin in patients with adult T cell leukemia-lymphoma | Clin. Cancer Res. | Tissue | CB703998 |
Ovarian Cancer | CD47 promotes cell growth and motility in epithelial ovarian cancer | Biomed. Pharmacother. | Tissue | CT565901 |
Ovarian Cancer | Identification and quantification of DNA repair protein poly(ADP ribose) polymerase 1 (PARP1) in human tissues and cultured cells by liquid chromatography/isotope-dilution tandem mass spectrometry | DNA Repair (Amst.) 2019 | Tissue | CP565393 |
Ovarian carcinoma tissue | Matrix Rigidity Activates Wnt Signaling through Down-regulation of Dickkopf-1 Protein | J. Biol. Chem., Jan 2013; 288: 141 - 151. | Tissue | |
Pancreas | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer | Mol. Cancer | Tissue | CD564366 |
Pancreas | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer | Mol. Cancer | Tissue | CD565370 |
Pancreas | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer | Mol. Cancer | Tissue | CD564282 |
pancreatic adenocarcinoma | A novel chimeric antigen receptor against PSCA mediates tumor destruction in a humanized mouse model of pancreatic cancer | Hum. Gene Ther. April 2014 | Tissue | |
Pancreatitis | Ca2+ Influx Channel Inhibitor SARAF Protects Mice From Acute Pancreatitis | Gastroenterology | Tissue | CR561065 |
Pancreatitis | Ca2+ Influx Channel Inhibitor SARAF Protects Mice From Acute Pancreatitis | Gastroenterology | Tissue | CR561741 |
Pancreatitis | Ca2+ Influx Channel Inhibitor SARAF Protects Mice From Acute Pancreatitis | Gastroenterology | Tissue | CR561222 |
Pancreatitis | Ca2+ Influx Channel Inhibitor SARAF Protects Mice From Acute Pancreatitis | Gastroenterology | Tissue | CR560152 |
Primary Tissue and DNA Samples | Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27) | PNAS, Feb 2012; 109: 2989 - 2994. | Tissue | |
prostate tumor total RNA | Targeting HOX transcription factors in prostate cancer | BMC Urol, Feb 2014. | Tissue | |
PS100059 | Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc-finger module | J. Biol. Chem. | Tissue | Tissue Lysate |
RNAs from colon adenocarcinomas | Inhibition of miR-193a Expression by Max and RXRa Activates K-Ras and PLAU to Mediate Distinct Aspects of Cellular Transformation | Cancer Res., Aug 2011; 71: 5144 - 5153. | Tissue | |
Salivary gland | Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report | Inflamm Regen | Tissue | CS811918 |
SCLC and Normal lung RNA | Expression of G protein-coupled receptor 19 in human lung cancer cells is triggered by entry into S phase and supports G2/M cell cycle progression | Mol. Cancer Res., Aug 2012; 10.1158/1541-7786.MCR-12-0139. | Tissue | |
SCLC and normal lung RNA samples | Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2–M Cell-Cycle Progression | Mol. Cancer Res., Oct 2012; 10: 1343 - 1358. | Tissue | |
Seminoma of testis | A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells | Int J Mol Sci | Tissue | CR562186 |
Seminoma of testis | A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells | Int J Mol Sci | Tissue | CR561980 |
Squamous carcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget | tissue | CP565792 |
Squamous carcinoma | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells | Oncotarget | tissue | CP565564 |
Testis mRNA | http://www.ncbi.nlm.nih.gov/pubmed/22387997 | Nature Genetics 44, 461-466 doi:10.1038/ng.1107 | Tissue | |
Testis RNA | Deciphering highly similar multigene family transcripts from Iso-Seq data with IsoCon | Nat Commun | Tissue | CR560016 |
Testis RNA | Deciphering highly similar multigene family transcripts from Iso-Seq data with IsoCon | Nat Commun | Tissue | CR561118 |
Tissue | Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA 221-5p Inflammatory Network in Human Colonic Epithelial Cells | CMGH Cellular and Molecular Gastroenterology and Hepatology | Tissue | |
Tissue | NDRG2–The Current Status of Expression, Functions and Regulation in Cancer and Identification of Alternative Splice Forms in Ovarian Cancer | Thesis | Tissue | |
Tissue | Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples | Cancer Res. | Tissue | Tissue |
Tissue | Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy | Proc. Natl. Acad. Sci. U.S.A. | Tissue | |
Tissue | Transient receptor potential canonical 1 (TRPC1) channels as regulators of sphingolipid- and VEGF receptor expression: implications for thyroid cancer cell migration and proliferation | J. Biol. Chem. | Tissue | |
Tissue | Testicular Expression of Adora3i2 in Adora3 Knockout Mice Reveals a Role of Mouse A3Ri2 and Human A3Ri3 Adenosine Receptors in Sperm | J. Biol. Chem., Oct 2010; 285: 33662 - 33670 | Tissue | |
Tissue | Control of ciliogenesis by FOR20, a novel centrosome and pericentriolar satellite protein | J. Cell Sci., Jul 2010; 123: 2391 - 2401 | Tissue | |
Tissue | An AP-3-dependent mechanism drives synaptic-like microvesicle biogenesis in pancreatic islet ß-cells | Am J Physiol Endocrinol Metab, Jul 2010; 299: E23 - E32 | Tissue | |
Tissue | Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors | Development, Jun 2010; 137: 1907 - 1917 | Tissue | |
Tissue | Alternative promoter and GATA5 transcripts in mouse | Am J Physiol Gastrointest Liver Physiol, Dec 2009; 297: G1214 - G1222 | Tissue | |
Tissue | A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice | Am J Physiol Endocrinol Metab, Dec 2009; 297: E1276 - E1282 | Tissue | |
Tissue | c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells | J. Exp. Med., Dec 2009; 206: 3001 - 3014 | Tissue | |
Tissue | mTORß Splicing Isoform Promotes Cell Proliferation and Tumorigenesis | J. Biol. Chem., Nov 2009; 284: 30807 - 30814 | Tissue | |
Tissue | Galectin-9 Is a High Affinity IgE-binding Lectin with Anti-allergic Effect by Blocking IgE-Antigen Complex Formation | J. Biol. Chem., Nov 2009; 284: 32344 - 32352 | Tissue | |
Tissue | Molecular Cloning, Expression and Characterization of A Novel Mouse SULT6 Cytosolic Sulfotransferase | J. Biochem., Sep 2009; 146: 399 - 405 | Tissue | |
Tissue | Cell Polarity Factor Par3 Binds SPTLC1 and Modulates Monocyte Serine Palmitoyltransferase Activity and Chemotaxis | J. Biol. Chem., Sep 2009; 284: 24881 - 24890 | Tissue | |
Tissue | ZBED4, a BED-Type Zinc-Finger Protein in the Cones of the Human Retina | Invest. Ophthalmol. Vis. Sci., Aug 2009; 50: 3580 - 3588 | Tissue | |
Tissue | Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models | J. Pharmacol. Exp. Ther., Oct 2008; 327: 268 - 276. | Tissue | |
Tissue | Remogliflozin etabonate, in a Novel Category of Selective Low-Affinity / High-Capacity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models | J. Pharmacol. Exp. Ther., Jun 2008; 10.1124/jpet.108.140210. | Tissue | |
Tissue | Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase | European Journal of Human Genetics 16, 1038 - 1049 (09 Apr 2008), | Tissue | |
Tissue | Primary Ciliary Dyskinesia in Mice Lacking the Novel Ciliary Protein Pcdp1 | Mol. Cell. Biol., Feb 2008; 28: 949 - 957. | Tissue | |
Tissue | Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, response to dietary folate restriction | Am J Physiol Cell Physiol. 2007 Nov;293(5):C1669-78. | Tissue | |
Tissue | A novel AAK1 splice variant functions at multiple steps of the endocytic pathway | Mol Biol Cell. 2007 Jul;18(7):2698-706. | Tissue | |
Tissue | Mucin Biosynthesis: Identification of the cis-Regulatory Elements of Human C2GnT-M Gene | Am J Respir Cell Mol Biol. 2007 Jun;36(6):737-45. | Tissue | |
Tissue | ELMOD2 is an Arl2 GTPase-activating protein that also acts on arfs | J Biol Chem. 2007 Jun 15;282(24):17568-80. | Tissue | |
Tissue | LPA4/GPR23 Is a Lysophosphatidic Acid (LPA) Receptor Utilizing Gs-, Gq/Gi-mediated Calcium Signaling and G12/13-mediated Rho Activation | J Biol Chem. 2007 Feb 16;282(7):4310-7. | Tissue | |
Tissue | Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level | J Pharmacol Exp Ther. 2007 Jan;320(1):323-30. | Tissue | |
Tissue | N-Glycosylation of the beta-propeller domain of the integrin alpha-5 subunit is essential for alpha-5-beta-1 heterodimerization, expression on the cell surface and its biological function | J. Biol. Chem. 2006 Nov 3;281(44):33258-67. | Tissue | |
Tissue | TIP-1 Has PDZ Scaffold Antagonist Activity | Mol. Biol. Cell, 2006 Oct;17(10):4200-11. | Tissue | |
Tissue | Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2 | J. Biol. Chem., 2006 Sep 22;281(38):28438-49. | Tissue | |
Tissue | Structural and Functional Abnormalities of Retinal Ribbon Synapses due to Cacna2d4 Mutation | Invest. Ophthalmol. Vis. Sci., Aug 2006; 47: 3523-3530. | Tissue | |
Tissue | Protein Phosphatase 6 Subunit with Conserved Sit4-associated Protein Domain Targets IkappaBepsilon | J. Biol. Chem., 2006 Aug 11;281(32):22624-34. | Tissue | |
Tissue | GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5 | J. Biol. Chem., 2006 Aug 18;281(33):23589-97. | Tissue | |
Tissue | Identification of the Maturation Factor for Dual Oxidase: Evolution Of An Eukaryotic Operon Equivalent | J. Biol. Chem., Jul 2006; 281: 18269-18272. | Tissue | |
Tissue | ATM Activation by Ionizing Radiation Requires BRCA1-associated BAAT1 | J. Biol. Chem., Apr 2006; 281: 9710-9718. | Tissue | |
Tissue | Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies | Hum. Mol. Genet., Apr 2006; 15: 1279-1289. | Tissue | |
Tissue | Origin and Evolution of Processed Pseudogenes That Stabilize Functional Makorin1 mRNAs in Mice, Primates and Other Mammals | Genetics, Apr 2006; 172: 2421 - 2429. | Tissue | |
Tissue | The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron–sulfur cluster biogenesis | Hum. Mol. Genet., Mar 2006; 15: 953-964. | Tissue | |
Tissue | Tandem chimerism as a means to increase protein complexity in the human genome | Genome Res., Jan 2006; 16: 37-44. | Tissue | |
Tissue | Ca2+–calmodulin-dependent myosin light chain kinase is essential for activation of TRPC5 channels expressed in HEK293 cells | J Physiol 2006 Jan 15;570(Pt 2):219-35. | Tissue | |
Tissue | Identification and Characterization of an Ovary-Selective Isoform of Epoxide Hydrolase | Biol Reprod Dec 2005 72, 968–975. | Tissue | |
Tissue | Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products | Glycobiology. 2005 Dec;15(12):1257-67. | Tissue | |
Tissue | PRMT8, a New Membrane-bound Tissue-specific Member of the Protein Arginine Methyltransferase Family | J Biol Chem. 2005 Sep 23;280(38):32890-6. | Tissue | |
Tissue | Gene expression analyses in X-linked myotubular myopathy | Neurology. 2005 Sep 13;65(5):732-7. | Tissue | |
Tissue | Synovial Sarcoma Translocation (SYT) Encodes a Nuclear Receptor Coactivator | Endocrinology Sept 2005; 146: 3892–3899 | Tissue | |
Tissue | Whole genome association study of rheumatoid arthritis using 27 039 microsatellites | Hum Mol Genet. 2005 Aug 15;14(16):2305-21. | Tissue | |
Tissue | Up-regulation of the ubiquitous alternative splicing factor Tra2b causes inclusion of a germ cell-specific exon | Hum Mol Genet. 2005 Aug 15;14(16):2289-303. | Tissue | |
Tissue | Pathological Aggression in “Fierce” Mice Corrected by Human Nuclear Receptor 2E1 | J Neurosci. 2005 Jul 6;25(27):6263-70. | Tissue | |
Tissue | N-Myristoyltransferase 1 Is Essential in Early Mouse Development | J Biol Chem. 2005 May 13;280(19):18990-5. | Tissue | |
Tissue | Cloning and Characterization of Mouse E2F8, a Novel Mammalian E2F Family Member Capable of Blocking Cellular Proliferation | J Biol Chem. 2005 May 6;280(18):18211-20. | Tissue | |
Tissue | MARCH-II is a syntaxin-6-binding protein involved in endosomal trafficking | Mol Biol Cell. 2005 Apr;16(4):1696-710. | Tissue | |
Tissue | Involvement of a Rac activator,P-Rex1, in neurotrophin-derived signaling and neuronal migration | J Neurosci. 2005 Apr 27;25(17):4406-19. | Tissue | |
Tissue | Oncostatin M Inhibits Proliferation of Rat Oval Cells, OC15-5, Inducing Differentiation into Hepatocytes | Am J Pathol Mar 2005, 166:709–719. | Tissue | |
Tissue | A Targeted Mutation of Nkd1 Impairs Mouse Spermatogenesis | J Biol Chem. 2005 Jan 28;280(4):2831-9. | Tissue | |
Tissue DNA | A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens | Melanoma Res. | Tissue | Tissue DNA |
Tissue FFPE Sections, Breast | Machine Learning for Nuclear Mechano-Morphometric Biomarkers in Cancer Diagnosis | Sci Rep | Tissue | CS708873 |
Tissue FFPE Sections, Breast | Machine Learning for Nuclear Mechano-Morphometric Biomarkers in Cancer Diagnosis | Sci Rep | Tissue | CS548359 |
Tissue RNA | Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain | Drug Metab. Dispos. | Tissue | Tissue RNA |
Tissue RNA | Identification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells | JCMGH | Tissue | Tissue RNA |
Tissue Samples | Glucagon regulates hepatic kisspeptin to impair insulin secretion | Cell Metab. 667-81 19 4. April 2014 | Tissue | |
Tissue Samples | The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics | NMR Biomed, Feb 2014. | Tissue | |
Tissue Total RNA, Liver | GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth | Sci Rep | Tissue | CR559730 |
Tissue Total RNA, Liver | GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth | Sci Rep | Tissue | CR560055 |
TissueFocus Cancer Survey Tissue Microarray, FFPE | CTP synthase forms the cytoophidium in human hepatocellular carcinoma | Exp. Cell Res.2017 | Tissue | CT565858 |
Tissues | Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis | J. Natl. Cancer Inst. | Tissue | |
Tissues | TAGLN2 regulates T cell activation by stabilizing the actin cytoskeleton at the immunological synapse | J. Cell Biol. | Tissue | |
Tissues | EDB Fibronectin Specific Peptide for Prostate Cancer Targeting | Bioconjug. Chem. | Tissue | |
Tissues | Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells | Int. J. Cancer | Tissue | |
Tissues | Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing | Pharmacogenomics J. | Tissue | |
Tissues | Chronic HIV infection is associated with upregulation of pro-inflammatory cytokine and chemokine and alpha defensin gene expression in colorectal mucosa | AIDS Res. Hum. Retroviruses | Tissue | |
Tissues | Reproducible, quantitative and flexible molecular sub-typing of clinical DLBCL samples using the NanoString nCounter system | Clin. Cancer Res. | Tissue | |
TMA | The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB® | EJNMMI Res, Jan 2014. | Tissue | |
TMA | Casein Kinase 1ε promotes cell proliferation by regulating mRNA translation | Cancer research | Tissue | |
Total RNA | SET contributes to the epithelial-mesenchymal transition of pancreatic cancer | Oncotarget | Tissue | CR562493 |
Various tissues | RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis | Cancer Res., Jun 2012; 72: 2879 - 2888. | Tissue | |
Within normal limits | Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy | Scientific reports | Tissue | CR560498 |
Within normal limits | Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy | Scientific reports | Tissue | CR560940 |
Within normal limits | Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy | Scientific reports | Tissue | CR560136 |
Within normal limits | Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells | Journal of translational medicine | Tissue | CP565585 |
Within normal limits | Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells | Journal of translational medicine | Tissue | CP565542 |
Within normal limits | Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells | Journal of translational medicine | Tissue | CP565443 |
Within normal limits | Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells | Journal of translational medicine | Tissue | CR560789 |
Within normal limits | Dodging COVID-19 Infection: Low Expression and Localization of ACE2 and TMPRSS2 in Human Umbilical Cord-Derived Mesenchymal Stem Cells | Research Square | Tissue | CP565585 |
Within normal limits | Dodging COVID-19 Infection: Low Expression and Localization of ACE2 and TMPRSS2 in Human Umbilical Cord-Derived Mesenchymal Stem Cells | Research Square | Tissue | CP565443 |
Within normal limits | Dodging COVID-19 Infection: Low Expression and Localization of ACE2 and TMPRSS2 in Human Umbilical Cord-Derived Mesenchymal Stem Cells | Research Square | Tissue | CP565542 |
Within normal limits | Dodging COVID-19 Infection: Low Expression and Localization of ACE2 and TMPRSS2 in Human Umbilical Cord-Derived Mesenchymal Stem Cells | Research Square | Tissue | CR560789 |
Within normal limits | Dodging COVID-19 Infection: Low Expression and Localization of ACE2 and TMPRSS2 in Human Umbilical Cord-Derived Mesenchymal Stem Cells | Research Square | Tissue | CR562469 |